Biohaven Ltd.
BHVNNYSEHealthcare● Active
$11.25
+$0.45(+4.12%)
Market Cap$1.2B
P/E Ratio—
52W High$18.566
52W Low$7.48
Biohaven Ltd. (BHVN) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · BHVN · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | ($0.00B) | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Margin %(computed) | — | — | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $0.64B | $0.80B | $0.37B | $0.44B | $0.18B |
| G&A Expenses | $0.11B | $0.09B | $0.06B | $0.13B | $0.04B |
| Total Operating Expenses | $0.74B | $0.89B | $0.44B | $0.57B | $0.22B |
| Operating Income | ($0.75B) | ($0.89B) | ($0.44B) | ($0.57B) | ($0.22B) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.01B | $0.02B | $0.02B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.74B) | ($0.85B) | ($0.41B) | ($0.57B) | ($0.21B) |
| Income Tax Expense | $0.00B | $0.00B | ($0.00B) | $0.00B | $0.00B |
| Net Income | ($0.74B) | ($0.85B) | ($0.41B) | ($0.57B) | ($0.21B) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-6.86 | $-9.28 | $-5.73 | $-12.75 | $-5.97 |
| Wtd Avg Shares | 0.11B | 0.09B | 0.07B | 0.04B | 0.04B |
| EBITDA | ($0.73B) | ($0.88B) | ($0.43B) | ($0.57B) | ($0.22B) |
| EBITDA Margin %(computed) | — | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Biohaven Ltd. data
About Biohaven Ltd. (BHVN) Income Statement
Biohaven Ltd. (BHVN) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, BHVN reported revenue of $0.00B, gross profit of ($0.00B) (gross margin —), and net income of ($0.74B) — a net profit margin of —.
Frequently asked questions
BHVN · 4 questionsBiohaven Ltd. (BHVN) reported revenue of $0.00B for 2025, down —% year-over-year.
BHVN revenueBHVN salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08